These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article. Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745 [TBL] [Abstract][Full Text] [Related]
4. Survival trends in elderly patients with glioblastoma multiforme: resective surgery, radiation, and chemotherapy. Patwardhan RV; Shorter C; Willis BK; Reddy P; Smith D; Caldito GC; Nanda A Surg Neurol; 2004 Sep; 62(3):207-13; discussion 214-5. PubMed ID: 15336860 [TBL] [Abstract][Full Text] [Related]
5. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
6. Impact of neuronavigation and image-guided extensive resection for adult patients with supratentorial malignant astrocytomas: a single-institution retrospective study. Kurimoto M; Hayashi N; Kamiyama H; Nagai S; Shibata T; Asahi T; Matsumura N; Hirashima Y; Endo S Minim Invasive Neurosurg; 2004 Oct; 47(5):278-83. PubMed ID: 15578340 [TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of prognostic factors in patients with glioblastoma. Lutterbach J; Sauerbrei W; Guttenberger R Strahlenther Onkol; 2003 Jan; 179(1):8-15. PubMed ID: 12540979 [TBL] [Abstract][Full Text] [Related]
8. Supratentorial glioblastoma treated with radiotherapy: use of the Radiation Therapy Oncology Group recursive partitioning analysis grouping for predicting survival. Fujii O; Soejima T; Kuwatsuka Y; Harada A; Ota Y; Tsujino K; Sasaki M; Kudo H; Nishihara M; Taomoto K Jpn J Clin Oncol; 2010 Aug; 40(8):726-31. PubMed ID: 20410057 [TBL] [Abstract][Full Text] [Related]
9. [Prognostic analysis of patients with cerebral glioma treated with radiotherapy]. Wu SX; Deng ML; Li QQ; Zhao C; Lu TX; Li FY; Cui NJ Ai Zheng; 2004 Nov; 23(11 Suppl):1561-6. PubMed ID: 15566680 [TBL] [Abstract][Full Text] [Related]
10. [The value of stereotactic biopsy and percutaneous radiation in therapy of glioblastoma multiforme]. Kreth FW; Warnke PC; Ostertag CB Nervenarzt; 1992 Aug; 63(8):480-4. PubMed ID: 1326087 [TBL] [Abstract][Full Text] [Related]
11. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy. Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019 [TBL] [Abstract][Full Text] [Related]
12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206 [TBL] [Abstract][Full Text] [Related]
13. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases. Nieder C; Andratschke N; Grosu AL; Molls M Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980 [TBL] [Abstract][Full Text] [Related]
14. Prognostic factors influencing clinical outcomes of glioblastoma multiforme. Li SW; Qiu XG; Chen BS; Zhang W; Ren H; Wang ZC; Jiang T Chin Med J (Engl); 2009 Jun; 122(11):1245-9. PubMed ID: 19567131 [TBL] [Abstract][Full Text] [Related]
15. [The prognostic factors in astrocytic tumors: analysis by the Kaplan-Meier method and the Weibull log-linear model]. Hirano H; Asakura T; Yokoyama S; Kadota K; Kasamo S; Okahara K; Hirakawa W; Niiro M; Nakamura K; Nakayama M; Yamasaki I No Shinkei Geka; 1996 Sep; 24(9):809-15. PubMed ID: 8827730 [TBL] [Abstract][Full Text] [Related]
16. Multifocal glioblastoma multiforme: prognostic factors and patterns of progression. Showalter TN; Andrel J; Andrews DW; Curran WJ; Daskalakis C; Werner-Wasik M Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):820-4. PubMed ID: 17499453 [TBL] [Abstract][Full Text] [Related]
17. Experiences with reoperation on recurrent glioblastoma multiforme. Pinsker M; Lumenta C Zentralbl Neurochir; 2001; 62(2):43-7. PubMed ID: 11786935 [TBL] [Abstract][Full Text] [Related]
18. A boost in addition to whole-brain radiotherapy improves patient outcome after resection of 1 or 2 brain metastases in recursive partitioning analysis class 1 and 2 patients. Rades D; Pluemer A; Veninga T; Dunst J; Schild SE Cancer; 2007 Oct; 110(7):1551-9. PubMed ID: 17654659 [TBL] [Abstract][Full Text] [Related]
19. A phase II trial of accelerated radiotherapy using weekly stereotactic conformal boost for supratentorial glioblastoma multiforme: RTOG 0023. Cardinale R; Won M; Choucair A; Gillin M; Chakravarti A; Schultz C; Souhami L; Chen A; Pham H; Mehta M Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1422-8. PubMed ID: 16750317 [TBL] [Abstract][Full Text] [Related]
20. Open-label simultaneous radio-chemotherapy of glioblastoma multiforme with topotecan in adults. Gross MW; Altscher R; Brandtner M; Haeusser-Mischlich H; Chiricuta IC; Siegmann AD; Engenhart-Cabillic R Clin Neurol Neurosurg; 2005 Apr; 107(3):207-13. PubMed ID: 15823676 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]